BRUKER CORP
BRKRAPI behind this page
BRKR FY 2025 request
Playground key active
/api/financials?ticker=BRKR&year=2025&quarter=4&full_year_mode=true
Pick an endpoint and run the request.Income Statement
| Metric | FY 2025 | FY 2024 | YoY |
|---|---|---|---|
| Revenue | 3,436.5 | 3,366.4 | +2.1% |
Show Product Lines breakouts |
|||
| Product | 2,766.4 | 2,759.2 | +0.3% |
| Product And Service Other | 670.1 | 607.2 | +10.4% |
Show Business Segments breakouts |
|||
| BEST | 263.2 | 268.9 | -2.1% |
| BEST · Intersegment Elimination | 7.7 | 14.1 | -45.4% |
| BEST · Operating Segments | 270.9 | 283 | -4.3% |
| BSI BioSpin | 878.8 | 905.7 | -3.0% |
| BSI BioSpin · Operating Segments | 878.8 | 905.7 | -3.0% |
| BSI CALID | 1,210.2 | 1,093.5 | +10.7% |
| BSI CALID · Operating Segments | 1,210.2 | 1,093.5 | +10.7% |
| BSI NANO | 1,084.3 | 1,098.3 | -1.3% |
| BSI NANO · Operating Segments | 1,084.3 | 1,098.3 | -1.3% |
Show Geography breakouts |
|||
| Asia Pacific Excluding China | 552.6 | 518.5 | +6.6% |
| CN | 475.8 | 471.2 | +1.0% |
| DE | 297 | 310.7 | -4.4% |
| Europe Excluding Germany | 950.2 | 873 | +8.8% |
| Other | 269.6 | 254.5 | +5.9% |
| US | 891.3 | 938.5 | -5.0% |
Show Consolidation Items breakouts |
|||
| Intersegment Elimination | 7.7 | 14.1 | -45.4% |
| Operating Segments | 3,444.2 | 3,380.5 | +1.9% |
Show Business Acquisition breakouts |
|||
| 2025 Acquisitions | 19.2 | — | — |
Show Timing Of Transfer Of Good Or Service breakouts |
|||
| Transferred At Point In Time | 2,920.7 | 2,894.9 | +0.9% |
| Transferred Over Time | 515.8 | 471.5 | +9.4% |
| Cost of Revenue | 1,858.8 | 1,716.9 | +8.3% |
Show Product Lines breakouts |
|||
| License | 9.9 | 10.1 | -2.0% |
| Product | 1,486.5 | 1,364.5 | +8.9% |
| Product And Service Other | 372.3 | 352.4 | +5.6% |
| Gross Profit | 1,577.7 | 1,649.5 | -4.4% |
| Selling, General & Administrative | 946.5 | 893.8 | +5.9% |
Show Product Lines breakouts |
|||
| Shipping And Handling | 50 | 45.7 | +9.4% |
Show Business Segments breakouts |
|||
| BEST · Operating Segments | 22.3 | 21.5 | +3.7% |
| BSI BioSpin · Operating Segments | 162.7 | 158.9 | +2.4% |
| BSI CALID · Operating Segments | 302.8 | 270.2 | +12.1% |
| BSI NANO · Operating Segments | 284 | 290.8 | -2.3% |
Show Consolidation Items breakouts |
|||
| Operating Segments | 771.8 | 741.4 | +4.1% |
| Research & Development | 395.2 | 376.5 | +5.0% |
Show Business Segments breakouts |
|||
| BEST · Operating Segments | 3.4 | 3.9 | -12.8% |
| BSI BioSpin · Operating Segments | 93.7 | 92.5 | +1.3% |
| BSI CALID · Operating Segments | 119.7 | 111.7 | +7.2% |
| BSI NANO · Operating Segments | 175.1 | 164.7 | +6.3% |
Show Consolidation Items breakouts |
|||
| Operating Segments | 391.9 | 372.8 | +5.1% |
| Goodwill Impairment Loss | 96.5 | — | — |
Show Business Segments breakouts |
|||
| BSI BioSpin | 42.5 | — | — |
| BSI NANO | 54 | — | — |
| Other Nonrecurring Income Expense | 71.3 | 126.1 | -43.5% |
| Operating Expenses | 1,509.5 | 1,396.4 | +8.1% |
| Operating Income | 68.2 | 253.1 | -73.1% |
Show Business Segments breakouts |
|||
| BEST · Operating Segments | 26.7 | 35.1 | -23.9% |
| BSI BioSpin · Operating Segments | 156.5 | 216.6 | -27.7% |
| BSI CALID · Operating Segments | 262.6 | 246.2 | +6.7% |
| BSI NANO · Operating Segments | 101.1 | 123.9 | -18.4% |
| Unallocated Expenses | 364.8 | 264.9 | +37.7% |
Show Consolidation Items breakouts |
|||
| Corporate, eliminations and other | 113.9 | 103.8 | +9.7% |
| Operating Segments | 546.9 | 621.8 | -12.0% |
| Other Non-Operating Income (Expense) | -46.2 | -38.2 | -20.9% |
| Income Before Taxes | 22 | 206.9 | -89.4% |
| Income Tax Expense (Benefit) | 29.3 | 91.4 | -67.9% |
| Equity In Income Losses Of Unconsolidated Investees Net Of Tax | -1 | -1.7 | +41.2% |
| Net Income | -8.3 | 113.8 | -107.3% |
| Net Income Loss Attributable To Noncontrolling Interest | 0.3 | 0.7 | -57.1% |
| Net Income | -8.6 | 113.1 | -107.6% |
Show Business Acquisition breakouts |
|||
| 2025 Acquisitions | 2.4 | — | — |
| Preferred Stock Dividends And Other Adjustments | 13.9 | — | — |
| Net Income Loss Available To Common Stockholders Basic | -22.5 | 113.1 | -119.9% |
| EPS (Basic) | -0.15 | 0.76 | -119.7% |
| EPS (Diluted) | -0.15 | 0.76 | -119.7% |
| Wtd Avg Shares (Basic) | 151.8 | 149 | +1.9% |
| Wtd Avg Shares (Diluted) | 151.8 | 149.5 | +1.5% |
| Non-Operating Income (Expense) | -46.2 | -46.2 | 0.0% |
| Interest Expense | -60.3 | -47.9 | -25.9% |
| Interest Income | 14.8 | 9.3 | +59.1% |
| Comprehensive Income | 15.4 | 3.6 | +327.8% |
| Other Comprehensive Income | 28.8 | -111.6 | +125.8% |
| Foreign Currency Transaction Gain Loss Before Tax | 11.6 | 23.7 | -51.1% |
Balance Sheet
| Metric | FY 2025 | FY 2024 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents | 298.8 | 183.4 | +62.9% |
| Accounts Receivable | 544.9 | 565.5 | -3.6% |
| Inventory | 1,094.6 | 1,067.8 | +2.5% |
| Other Assets Current | 274.2 | 236.5 | +15.9% |
| Total Current Assets | 2,212.5 | 2,053.2 | +7.8% |
| Non-Current Assets | |||
| Property, Plant & Equipment | 744.8 | 669.3 | +11.3% |
| Goodwill | 1,547.7 | 1,507.3 | +2.7% |
Show Business Segments breakouts |
|||
| BEST | 0.3 | 0.3 | 0.0% |
| BSI BioSpin | 202.7 | 221.2 | -8.4% |
| BSI CALID | 818.9 | 716 | +14.4% |
| BSI NANO | 525.8 | 569.8 | -7.7% |
Show Consolidation Items breakouts |
|||
| Operating Segments | 46.9 | 958 | -95.1% |
Show Business Acquisition breakouts |
|||
| Other | 12.6 | 75.6 | -83.3% |
| Recipe | 34.3 | — | — |
| Operating Lease Right-of-Use Assets | 165.8 | 145.5 | +14.0% |
| Deferred Tax Assets | 421.7 | 286.2 | +47.3% |
| Other Non-Current Assets | 249.3 | 232.7 | +7.1% |
| Total Assets | 6,241.4 | 5,806.7 | +7.5% |
Show Business Segments breakouts |
|||
| BEST · Operating Segments | 192.4 | 199.8 | -3.7% |
| BSI BioSpin, BSI CALID, BSI NANO & Corporate · Operating Segments | 6,094.2 | 5,648.4 | +7.9% |
Show Consolidation Items breakouts |
|||
| Corporate, eliminations and other | -45.2 | -41.5 | -8.9% |
| Intangible Assets | 899.6 | 912.5 | -1.4% |
Show Finite Lived Intangible Assets By Major Class breakouts |
|||
| Customer Relationships | 425.5 | 425 | +0.1% |
| Other Intangible Assets | 4.5 | 9.5 | -52.6% |
| Technology Based Intangible Assets | 429.1 | 433.2 | -0.9% |
| Trade Names | 40.5 | 44.8 | -9.6% |
| Other Assets | |||
| Intangible Assets Net Excluding Goodwill | 899.6 | 912.5 | -1.4% |
| Current Liabilities | |||
| Long Term Debt And Capital Lease Obligations Current | 16.6 | 32.5 | -48.9% |
| Accounts Payable | 215.9 | 234.1 | -7.8% |
| Deferred Revenue (Current) | 441.3 | 438.2 | +0.7% |
| Other Liabilities Current | 605.4 | 576.5 | +5.0% |
| Total Current Liabilities | 1,279.2 | 1,281.3 | -0.2% |
| Non-Current Liabilities | |||
| Long-Term Debt | 1,852.5 | 2,061.8 | -10.2% |
| Contract With Customer Liability Noncurrent | 109.1 | 100 | +9.1% |
| Deferred Tax Liabilities | 112.5 | 118.5 | -5.1% |
| Operating Lease Liabilities | 138.6 | 118.9 | +16.6% |
| Other Non-Current Liabilities | 239.2 | 311 | -23.1% |
| Total Liabilities | 3,731.1 | 3,991.5 | -6.5% |
| Long-Term Debt | 1,869.1 | 2,094.3 | -10.8% |
Show Debt Instrument breakouts |
|||
| Finance Lease Obligations | 19 | 17.5 | +8.6% |
| Accrued Income Taxes Noncurrent | 82 | 73.9 | +11.0% |
| Other Liabilities | |||
| Redeemable Noncontrolling Interest Equity Carrying Amount | 36.8 | 18.1 | +103.3% |
| Stockholders' Equity | |||
| Common Stock | 1.8 | 1.8 | 0.0% |
| Treasury Stock Value | -1,242.2 | -1,237.2 | -0.4% |
| Additional Paid In Capital Common Stock | 1,414.6 | 713.4 | +98.3% |
| Retained Earnings | 2,361.8 | 2,406.7 | -1.9% |
| Accumulated Other Comprehensive Income | -79.5 | -103.5 | +23.2% |
| Total Stockholders' Equity | 2,456.5 | 1,781.2 | +37.9% |
| Minority Interest | 17 | 15.9 | +6.9% |
| Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 2,473.5 | 1,797.1 | +37.6% |
Show Equity Components breakouts |
|||
| Accumulated Other Comprehensive Income | -79.5 | -103.5 | +23.2% |
| Additional Paid In Capital | 1,414.6 | 713.4 | +98.3% |
| Common Stock | 1.8 | 1.8 | 0.0% |
| Noncontrolling Interest | 17 | 15.9 | +6.9% |
| Parent | 2,456.5 | 1,781.2 | +37.9% |
| Redeemable Noncontrolling Interests | 36.8 | 18.1 | +103.3% |
| Retained Earnings | 2,361.8 | 2,406.7 | -1.9% |
| Treasury Stock Common | -1,242.2 | -1,237.2 | -0.4% |
| Total Liabilities & Equity | 6,241.4 | 5,806.7 | +7.5% |
Cash Flow Statement
| Metric | FY 2025 | FY 2024 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Depreciation & Amortization | 220.3 | 183.8 | +19.9% |
Show Business Segments breakouts |
|||
| BEST | 9.4 | 8.4 | +11.9% |
| BSI BioSpin | 43.2 | 41 | +5.4% |
| BSI CALID | 92.3 | 67 | +37.8% |
| BSI NANO | 67.2 | 61.7 | +8.9% |
| Corporate | 8.2 | 5.7 | +43.9% |
| Stock-Based Compensation | 20.2 | 25.3 | -20.2% |
| Deferred Income Taxes | -104.5 | -63.8 | -63.8% |
| Impairment Charges Of Tangible And Intangible Assets Including Goodwill | 152.3 | 28.5 | +434.4% |
| Inventory Write Down | 76 | 60.2 | +26.2% |
| Acquisition Related Hybrid Liability Adjustments Related To Operating Activities | -49 | 20.3 | -341.4% |
| Foreign Currency Transaction Gain Loss Net | -56 | -28.1 | -99.3% |
| Other Non-Cash Items | 27.9 | 22.1 | +26.2% |
| Change in Accounts Receivable | 54.2 | -40.6 | +233.5% |
| Change in Inventory | 12.1 | -69.8 | +117.3% |
| Change in Accounts Payable | -37.5 | 20.8 | -280.3% |
| Increase Decrease In Employee Related Liabilities | -26.7 | 15.4 | -273.4% |
| Increase Decrease In Accrued Income Taxes Payable | -94 | -15.3 | -514.4% |
| Increase Decrease In Deferred Revenue | -22.9 | -52.8 | +56.6% |
| Increase Decrease In Other Operating Capital Net | -30 | 23.5 | -227.7% |
| Net Cash from Operations | 134.1 | 251.3 | -46.6% |
| Investing Activities | |||
| Capital Expenditures | -90.8 | -115.3 | +21.2% |
| Payments For Proceeds From Investments | -7.2 | -48.3 | +85.1% |
| Payments To Acquire Businesses Net Of Cash Acquired | -73.9 | -1,599.6 | +95.4% |
| Cash Paid For In Process Research And Development And Related Assets | -29.4 | — | — |
| Other Investing Activities | 4.8 | 5.9 | -18.6% |
| Net Cash from Investing | -196.5 | -1,757.3 | +88.8% |
| Financing Activities | |||
| Repayments Of Lines Of Credit | -778.8 | -1,212.7 | +35.8% |
Show Long-Term Debt Type breakouts |
|||
| 2024 Amended and Restated Credit Agreement | -778.8 | -1,212.7 | +35.8% |
| Proceeds From Lines Of Credit | 750.5 | 1,250.3 | -40.0% |
Show Long-Term Debt Type breakouts |
|||
| 2024 Amended and Restated Credit Agreement | 750.5 | 981.4 | -23.5% |
| Repayments Of Long Term Debt | -466.5 | -135.4 | -244.5% |
Show Long-Term Debt Type breakouts |
|||
| 2019 Term Loan | -255.8 | — | — |
| 2024 Term Loan Due in 2027 | -37.6 | — | — |
| CHF Notes Under the 2024 Term Loan Agreement | -189.4 | -6.4 | -2859.4% |
| USD notes under the 2019 Term Loan Agreement | -263.3 | -15 | -1655.3% |
| Proceeds From Issuance Of Long Term Debt | 3.5 | 973.7 | -99.6% |
| Proceeds From Issuance Of Redeemable Convertible Preferred Stock | 669.7 | — | — |
| Proceeds From Issuance Of Common Stock | 7.9 | 409 | -98.1% |
| Payments Of Dividends Preferred Stock And Preference Stock | -10.1 | — | — |
| Payments Of Dividends Common Stock | -22.8 | -30.2 | +24.5% |
| Share Repurchases | -10 | — | — |
| Proceeds From Payments For Other Financing Activities | -8.3 | -24.9 | +66.7% |
| Net Cash from Financing | 135.1 | 1,229.8 | -89.0% |
| Supplemental | |||
| Interest Paid | 71 | 54.6 | +30.0% |
| Income Taxes Paid | 222.5 | 153.9 | +44.6% |
| Restricted Cash And Cash Equivalents | 4.3 | 3.3 | +30.3% |
| Income Taxes Paid | 222.5 | — | — |
| Other Cash Flow | |||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 43.7 | -28.7 | +252.3% |
| Net Change in Cash | 116.4 | -304.9 | +138.2% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 303.1 | 186.7 | +62.3% |
Values in millions USD. Source: SEC EDGAR 10-K filing.